Beijing Leadman Biochemist (300289.SZ) traded flat 0 % during a 24 hours period ending at 11:56 PM Central Europe on Monday 26th. One Beijing Leadman Biochemist stock can currently be bought for about CNY 5.64 on popular exchanges. Current supply of Beijing Leadman Biochemist stocks is 544.3 mn. Beijing Leadman Biochemist has a current market capitalization of CNY 3 bn and approximately CNY 45.8 mn worth of Beijing Leadman Biochemist was traded on exchanges in the last 24 hours. Since last month end, Beijing Leadman Biochemist has traded -6.9 % down. Simple moving average of last 200 days is at CNY 5.8. The highest price of past 52 weeks was recorded at CNY 10.41 on 11/14/2025. 52 weeks low was at CNY 5.19 on 07/09/2026.
Here is how related stocks have performed in the past 24 hours:
Nanjing Well Pharmaceutica (603351.SS) traded flat 0 % and now trades at CNY 26.82. Current market capitalisation for Nanjing Well Pharmaceutica is CNY 3.6 bn. Nanjing Well Pharmaceutica has a current price to earnings ratio of 22.75.
Nms (001360.SZ) traded flat 0 % and now trades at CNY 16.09. Nms has a market capitalisation of CNY 3.6 bn. NMS reported its third‑quarter earnings for the year, showing a notable increase in revenue and profitability compared with the same period a year earlier. Management highlighted strong demand in its core markets, attributing the upward trend to robust customer activity and the successful launch of new products that broadened its portfolio. The company also announced a revision of its 2026 investment plan, raising the forecasted capital allocation to better support expansion and technological upgrades. This adjustment reflects confidence in continued market growth and a commitment to enhancing operational efficiency. Analysts noted that the company’s performance aligns with broader sector improvements, especially in technology and industrial segments, and that the revised investment strategy positions NMS to capture emerging opportunities in its key business areas.
Danyang Syngen Intelligent (603007.SS) traded flat 0 % and now trades at CNY 4.59. Danyang Syngen Intelligent has a market capitalisation of CNY 3.6 bn.
Heren Health (300550.SZ) traded flat 0 % and now trades at CNY 12.74. Heren Health has a market capitalisation of CNY 3.6 bn. Current price/earnings ratio for Heren Health is 154.28.
Hefei Lifeon Pharmaceutica (003020.SZ) traded flat 0 % and now trades at CNY 16.06. Current market capitalisation for Hefei Lifeon Pharmaceutica is CNY 3.6 bn. Hefei Lifeon Pharmaceutica has a current price to earnings ratio of 24.66.
About Beijing Leadman Biochemist
Beijing Leadman Biochemistry Co.,Ltd. is a company based in China that specializes in the research and development, manufacture, and sale of in vitro diagnostic products. It offers biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. Additionally, the company provides biochemistry diagnostic and companion reagents. To aid in clinical tasks, medical instruments such as EnigmaML, an automated molecular test platform, DiaSys InnovaStar, an automatic compact POCT analyzer, DiaSys Respons, a random access benchtop analyzer, CI1000 automatic chemiluminescence immunoassay analyzers, and IDS-isys, an instrument to enhance performance and productivity, are also available. The company was founded in 1997 and has its main office in Beijing, the People’s Republic of China.